Novartis Gets No Fees Despite 'Exceptional' Patent Case
A Maryland federal judge on Tuesday refused to grant Novartis Corp. attorneys' fees in an "exceptional" patent infringement case brought against it by a defunct nonpracticing entity in multidistrict litigation, saying...To view the full article, register now.
Already a subscriber? Click here to view full article